| pubmed-article:18302515 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C0025266 | lld:lifeskim |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C1337013 | lld:lifeskim |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C0040165 | lld:lifeskim |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C0284930 | lld:lifeskim |
| pubmed-article:18302515 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
| pubmed-article:18302515 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18302515 | pubmed:dateCreated | 2008-2-27 | lld:pubmed |
| pubmed-article:18302515 | pubmed:abstractText | Thyroid hormone administration is associated with low bone density in some studies. The aim of the present study was to evaluate the influence L-thyroxine, in doses used to treat patients with a history of thyroid carcinoma, on serum cathepsin K and other markers of bone metabolism. Cathepsin K is thought to have a role in osteoclast mediated bone resorption. | lld:pubmed |
| pubmed-article:18302515 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18302515 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18302515 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18302515 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18302515 | pubmed:issn | 1050-7256 | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:LindPeterP | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:Kerschan-Schi... | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:PietschmannPe... | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:WoloszczukWol... | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:KudlacekStefa... | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:MikoschPeterP | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:KresnikEwaldE | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:StettnerHaroH | lld:pubmed |
| pubmed-article:18302515 | pubmed:author | pubmed-author:GallowitschHa... | lld:pubmed |
| pubmed-article:18302515 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18302515 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:18302515 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18302515 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18302515 | pubmed:pagination | 27-33 | lld:pubmed |
| pubmed-article:18302515 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:meshHeading | pubmed-meshheading:18302515... | lld:pubmed |
| pubmed-article:18302515 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18302515 | pubmed:articleTitle | High cathepsin K levels in men with differentiated thyroid cancer on suppressive L-thyroxine therapy. | lld:pubmed |
| pubmed-article:18302515 | pubmed:affiliation | Department of Internal Medicine II, Klagenfurt State Hospital, Klagenfurt, Austria. peter.mikosch@tele2.at | lld:pubmed |
| pubmed-article:18302515 | pubmed:publicationType | Journal Article | lld:pubmed |
